Sarpogrelate attenuates pulmonary arterial hypertension via calcium calcineurin axis
Frontiers in Bioscience · 2019 · 24 (4) · 607-615
DOI: 10.2741/4739 ↗At a glance
Journal article in Frontiers in Bioscience, 2019. Written by Junli Han and 3 co-authors. Institution: Critical Care Medicine Department, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an , China. Cited 7 times so far (Crossref).
Abstract (original language)
Pulmonary arterial hypertension (PAH) is a syndrome caused by restricted blood flow in the pulmonary circulation, which results in a poor patient prognosis. The serotonin (5-HT), TRPC1 (Transient receptor potencial channel 1), TRPC6 (Transient receptor potencial channel 6), calcineurin A, and NFATc3 (an isoform of nuclear factor of activated T-cells family) are involved in cell proliferation and hypertrophy and the crosstalk between these molecules may play an essential role in the pathogenesis of pulmonary arterial hypertension. We hypothesized that 5-HT promotes PAH by affecting TRPC channels. We investigated the effects of sarpogrelate, a 5-HT2A receptor antagonist, on pulmonary arterial pressure, cardiac remodeling, pulmonary artery remodeling, and TRPC1, TRPC6, calcineurin A, and NFATc3 expression in pulmonary arteries from rats with PAH. The results showed that sarpogrelate reduced pulmonary arterial pressure, cardiac remodeling, pulmonary artery remodeling, and expression of TRPC1, TRPC6, calcineurin A, and NFATc3 in pulmonary arteries. In conclusion, Sarpogrelate reduced the severity of PAH in rat model and decreased the expression of TRPC1, TRPC6, calcineurin A, and NFATc3 in pulmonary arteries.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Critical Care Medicine Department, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an , China.
- Peripheral Vascular Department, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an , China, tianhongyanxg@163.com.
- Respiration Department, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an , China.
- Peripheral Vascular Department, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an , China.
Cite
APA
Han, J., Tian, H., Liu, Y., & Fan, F. (2019). Sarpogrelate attenuates pulmonary arterial hypertension via calcium calcineurin axis. Frontiers in Bioscience, 24(4), 607-615. https://doi.org/10.2741/4739
Vancouver
Han J, Tian H, Liu Y, Fan F. Sarpogrelate attenuates pulmonary arterial hypertension via calcium calcineurin axis. Frontiers in Bioscience. 2019;24(4):607-615. doi:10.2741/4739
BibTeX
@article{Han2019,
author = {Han, Junli and Tian, Hongyan and Liu, Ya and Fan, Fenling},
title = {Sarpogrelate attenuates pulmonary arterial hypertension via calcium calcineurin axis},
journal = {Frontiers in Bioscience},
year = {2019},
volume = {24},
number = {4},
pages = {607--615},
doi = {10.2741/4739}
}
EUVIMED